Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

GBPDC: Gut-Brain in PD Consortium Master Protocol

Trial N/A Not yet recruiting May 4, 2026

Accelerated Temporal Interference Stimulation on Bilateral Subthalamic Nucleus for Parkinson's Disease and Secondary Parkinson's Syndrome

Trial N/A Recruiting May 4, 2026

Simplified, Scalable, 24-hour Adaptive DBS in Parkinson's Disease

Trial N/A Recruiting May 4, 2026

Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients

Trial Early Phase 1 Completed May 4, 2026

Attention and Eye Movement in Parkinson's Disease

Trial N/A Recruiting May 4, 2026

Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.

Trial Phase 1 Recruiting May 3, 2026

Robotic Gait Rehabilitation in Parkinson's Disease

Trial N/A Terminated May 3, 2026

Cerebellar Transcranial Alternating Current Stimulation (tACS) to Modulate Parkinson's Disease Tremor

Trial N/A Recruiting May 3, 2026

Effects of PR Oxycodone and of Levodopa, vs Placebo, on Central Neuropathic Pain in Parkinson's Disease

Trial Phase 2 Completed May 3, 2026

" Visual Characterization of Parkinson's Patients and Oculomotor or Perceptual Therapy"

Trial N/A Completed May 3, 2026

Acute Effects of AMPS on Cardiovascular, Functional Capacity and Postural Control in Patients With Parkinson's Disease

Trial N/A Completed April 30, 2026

Direct Measurement of Motor Cortical Responses to tDCS

Trial N/A Completed April 30, 2026

Pain Assessment in Patients With Idiopathic Rapid Eye Movement (REM) Sleep Behaviour Disorder

Trial N/A Recruiting April 30, 2026

Understanding Alpha-Synuclein Spread in Parkinson's Disease Through Blood Biomarkers and Neuroimaging

Trial N/A Not yet recruiting April 30, 2026

A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R08b in Parkinson's Disease Patients With GBA1 Mutations

Trial Phase 1 Not yet recruiting April 30, 2026

Evaluation of Neuroinflammation in Parkinson's Disease Using 18F-NOS PET/CT

Trial Early Phase 1 Active, not recruiting April 30, 2026

Adaptive Deep Brain Stimulation to Improve Motor and Gait Functions in Parkinson's Disease

Trial N/A Active, not recruiting April 30, 2026

tDCS on Parkinson's Disease Cognition

Trial N/A Recruiting April 30, 2026

Virtual Reality on Balance of Parkinson's Disease

Trial N/A Active, not recruiting April 29, 2026

Using Low Intensity Focused Ultrasound to Modulate Deep Brain Areas for Tremor Control in Parkinson's Disease Patients.

Trial N/A Completed April 29, 2026